Skip to main content

Table 3 Actual Symptoms and diagnoses recorded as Read codes by the treating primary care physician within 3 months of orlistat discontinuation (n = 79)

From: Unplanned medication discontinuation as a potential pharmacovigilance signal: a nested young person cohort study

System Number of patients (%) Symptoms Frequency
Respiratory 8 (10.1%) Influenza 3
Acute tonsillitis 3
Acute bronchitis and bronchiolitis 2
Asthma 1
Chest infection 1
Acute laryngitis and tracheitis 1
Upper respiratory infection 1
Cough 1
Respiratory symptom 1
Genitourinary 7 (8.9%) Treatment via bladder catheter 5
Retention of urine 1
Urinary tract infection (UTI) 1
Suspected UTI 2
Cystitis 1
Dermatology 6 (7.6%) Rash and other non-specific skin eruption 1
Dermatitis 1
Skin cyst 1
Chalazion (meibomian cyst) 1
Acne vulgaris 1
Unilateral mastalgia 1
Lump in breast 1
Psoriasis and similar disorders 1
Endocrine 6 (7.6%) Obesity 4
Acquired hypothyroidism 2
Gynaecomastia 3
Obstetrics & Gynaecology 4 (5.1%) Menorrhagia 1
Dysmenorrhoea 1
Spontaneous abortion 1
Codes related to spontaneous abortion 6
Polycystic ovarian syndrome 1
Gastrointestinal 4 (5.1%) Non-infective gastritis 1
Gastritis 1
Abdominal pain 3
Abdominal discomfort 1
Irritable bowel syndrome 1
Musculoskeletal 4 (5.1%) Backache 1
Pain in lumbar spine 1
Closed fracture of radius 1
Temporomandibular joint disorder 1
Arthralgia of knee 1
Mental health and behavioural 3 (3.8%) Social phobias 4
Loss of confidence 1
Anxiety state 1
Depressed mood 4
At risk of deliberate self harm 1
Central nervous system 3 (3.8%) In-coordination 1
Tiredness 1
Migraine 1
Headache 1
Infantile autism 1
Infection 3 (3.8%) Viral infection 3